This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim Io Canada Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Dorothea Maetzel: Innovator in Antibody Research
Introduction
Dorothea Maetzel is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Dorothea holds a patent for "FLT3 Agonist Antibodies and Uses Thereof." This innovative patent reflects her expertise in antibody research and its applications in treating various diseases. The patent showcases her ability to contribute to cutting-edge medical solutions.
Career Highlights
Dorothea is currently employed at Boehringer Ingelheim (Canada) Inc., where she continues to push the boundaries of scientific research. Her role at the company allows her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Arif Jetha and Phil Gobeil. Their collaborative efforts contribute to the innovative environment at Boehringer Ingelheim, fostering advancements in biotechnology.
Conclusion
Dorothea Maetzel is a trailblazer in the field of antibody research, with a focus on developing therapeutic solutions. Her patent and work at Boehringer Ingelheim highlight her dedication to innovation in healthcare.